LEGN logo

Legend Biotech Corporation (LEGN) EBIT

annual EBIT:

-$309.57M+$132.65M(+30.00%)
December 31, 2024

Summary

  • As of today (September 14, 2025), LEGN annual earnings before interest & taxes is -$309.57 million, with the most recent change of +$132.65 million (+30.00%) on December 31, 2024.
  • During the last 3 years, LEGN annual EBIT has risen by +$84.43 million (+21.43%).
  • LEGN annual EBIT is now -2346.36% below its all-time high of $13.78 million, reached on December 1, 2017.

Performance

LEGN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

quarterly EBIT:

-$119.58M-$25.51M(-27.12%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LEGN quarterly earnings before interest & taxes is -$119.58 million, with the most recent change of -$25.51 million (-27.12%) on June 30, 2025.
  • Over the past year, LEGN quarterly EBIT has dropped by -$107.09 million (-857.68%).
  • LEGN quarterly EBIT is now -361.87% below its all-time high of $45.66 million, reached on December 31, 2024.

Performance

LEGN quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

TTM EBIT:

-$283.36M-$107.09M(-60.75%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LEGN TTM earnings before interest & taxes is -$283.36 million, with the most recent change of -$107.09 million (-60.75%) on June 30, 2025.
  • Over the past year, LEGN TTM EBIT has dropped by -$18.75 million (-7.09%).
  • LEGN TTM EBIT is now -2186.67% below its all-time high of -$12.39 million, reached on March 31, 2019.

Performance

LEGN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LEGN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.0%-857.7%-7.1%
3 y3 years+21.4%+37.5%+37.9%
5 y5 years-125.9%+11.3%-5.7%

LEGN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+32.4%-361.9%+38.3%-107.6%+44.8%
5 y5-year-125.9%+32.4%-361.9%+38.3%-107.6%+44.8%
alltimeall time-2346.4%+32.4%-361.9%+38.3%-2186.7%+44.8%

LEGN EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$119.58M(+27.1%)
-$283.36M(+60.8%)
Mar 2025
-
-$94.07M(-306.0%)
-$176.27M(+29.1%)
Dec 2024
-$309.57M(-30.0%)
$45.66M(-139.6%)
-$136.52M(-57.8%)
Sep 2024
-
-$115.38M(+824.1%)
-$323.17M(+22.1%)
Jun 2024
-
-$12.49M(-77.0%)
-$264.61M(-40.6%)
Mar 2024
-
-$54.31M(-61.5%)
-$445.78M(-10.5%)
Dec 2023
-$442.22M(-3.5%)
-$140.99M(+148.1%)
-$498.32M(+2.1%)
Sep 2023
-
-$56.82M(-70.7%)
-$488.19M(-4.8%)
Jun 2023
-
-$193.65M(+81.2%)
-$512.93M(+0.4%)
Mar 2023
-
-$106.86M(-18.3%)
-$510.71M(+17.4%)
Dec 2022
-$458.05M(+16.3%)
-$130.86M(+60.5%)
-$434.93M(+5.4%)
Sep 2022
-
-$81.56M(-57.4%)
-$412.79M(-9.6%)
Jun 2022
-
-$191.43M(+515.9%)
-$456.41M(+28.0%)
Mar 2022
-
-$31.08M(-71.4%)
-$356.52M(-15.1%)
DateAnnualQuarterlyTTM
Dec 2021
-$394.00M(+71.1%)
-$108.72M(-13.2%)
-$420.00M(+12.4%)
Sep 2021
-
-$125.18M(+36.8%)
-$373.67M(+18.5%)
Jun 2021
-
-$91.53M(-3.2%)
-$315.45M(-12.1%)
Mar 2021
-
-$94.56M(+51.6%)
-$358.71M(+16.4%)
Dec 2020
-$230.27M(+68.0%)
-$62.39M(-6.8%)
-$308.09M(+0.3%)
Sep 2020
-
-$66.96M(-50.3%)
-$307.30M(+14.6%)
Jun 2020
-
-$134.79M(+206.7%)
-$268.04M(+65.8%)
Mar 2020
-
-$43.95M(-28.7%)
-$161.70M(+24.2%)
Dec 2019
-$137.05M(+788.0%)
-$61.60M(+122.3%)
-$130.15M(+89.9%)
Sep 2019
-
-$27.71M(-2.6%)
-$68.55M(+67.9%)
Jun 2019
-
-$28.45M(+129.6%)
-$40.84M(+229.6%)
Mar 2019
-
-$12.39M
-$12.39M
Dec 2018
-$15.43M(-212.0%)
-
-
Dec 2017
$13.78M
-
-

FAQ

  • What is Legend Biotech Corporation annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Legend Biotech Corporation?
  • What is Legend Biotech Corporation annual EBIT year-on-year change?
  • What is Legend Biotech Corporation quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Legend Biotech Corporation?
  • What is Legend Biotech Corporation quarterly EBIT year-on-year change?
  • What is Legend Biotech Corporation TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Legend Biotech Corporation?
  • What is Legend Biotech Corporation TTM EBIT year-on-year change?

What is Legend Biotech Corporation annual earnings before interest & taxes?

The current annual EBIT of LEGN is -$309.57M

What is the all time high annual EBIT for Legend Biotech Corporation?

Legend Biotech Corporation all-time high annual earnings before interest & taxes is $13.78M

What is Legend Biotech Corporation annual EBIT year-on-year change?

Over the past year, LEGN annual earnings before interest & taxes has changed by +$132.65M (+30.00%)

What is Legend Biotech Corporation quarterly earnings before interest & taxes?

The current quarterly EBIT of LEGN is -$119.58M

What is the all time high quarterly EBIT for Legend Biotech Corporation?

Legend Biotech Corporation all-time high quarterly earnings before interest & taxes is $45.66M

What is Legend Biotech Corporation quarterly EBIT year-on-year change?

Over the past year, LEGN quarterly earnings before interest & taxes has changed by -$107.09M (-857.68%)

What is Legend Biotech Corporation TTM earnings before interest & taxes?

The current TTM EBIT of LEGN is -$283.36M

What is the all time high TTM EBIT for Legend Biotech Corporation?

Legend Biotech Corporation all-time high TTM earnings before interest & taxes is -$12.39M

What is Legend Biotech Corporation TTM EBIT year-on-year change?

Over the past year, LEGN TTM earnings before interest & taxes has changed by -$18.75M (-7.09%)
On this page